| 1. | | Recruiting | Genetic Markers for Focal Segmental Glomerulosclerosis
Conditions: AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections |
| 2. | | Recruiting | Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Diseases; Chronic Disease |
| 3. | | Recruiting | Pirfenidone: A New Drug to Treat Kidney Disease in Patients with Diabetes
Conditions: Diabetes Mellitus; Diabetic Nephropathy |
| 4. | | Recruiting | Determination of Kidney Function
Condition: Kidney Disease |
| 5. | | Recruiting | Study to Assess Darbepoetin Alfa in Subjects with Chronic Kidney Disease
Conditions: Kidney Disease; Chronic Disease |
| 6. | | Recruiting | Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
Condition: Kidney Disease |
| 7. | | Recruiting | Angiotensin II Blockade
Conditions: Kidney Disease; Proteinuria |
| 8. | | Recruiting | Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients with End Stage Renal Disease Receiving Hemodialysis
Conditions: End Stage Renal Disease; Hyperhomocysteinemia |
| 9. | | Recruiting | Evaluation of Autosomal Recessive Polycystic Kidney Disease and Congenital Hepatic Fibrosis
Condition: Polycystic Kidney, Autosomal Recessive |
| 10. | | Not yet recruiting | Clinical Trial to Slow the Progression of ADPKD
Conditions: Kidney, Polycystic; Kidney, Polycystic, Autosomal Dominant |
| 11. | | Recruiting | Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT)
Conditions: Kidney Diseases; Nephritis; Diabetes Mellitus |
| 12. | | Recruiting | Omega-3 Fatty Acids that Affect the Immune System in Kidney Transplant Patients
Condition: Kidney Diseases |
| 13. | | Recruiting | Dynamic Aspects of Amino Acid Metabolism
Condition: Kidney Diseases |
| 14. | | Recruiting | Matrix metalloproteinases and Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 1; Diabetic Nephropathy |
| 15. | | Recruiting | Treatment of Diabetic Nephropathy
Condition: Diabetic Nephropathy |
| 16. | | Recruiting | The genetics of kidneys in diabetes (GoKinD) study
Condition: Diabetic Nephropathy |
| 17. | | Recruiting | Cause of Focal Segmental Glomerulosclerosis
Conditions: AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections |
| 18. | | Not yet recruiting | Optimal Treatment for Kidney Disease in HIV Infected Adults
Conditions: HIV Infections; Kidney Disease |
| 19. | | Recruiting | RO0503821 Treatment for Correction of Anemia in Chronic Kidney Disease Patients
Conditions: Anemia; Kidney Disease |
| 20. | | Recruiting | MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery
Conditions: Renal Artery Obstruction; Kidney Disease |
| 21. | | Recruiting | Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants
Condition: Kidney Disease |
| 22. | | Recruiting | Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants
Conditions: Graft Rejection; Kidney Disease |
| 23. | | Recruiting | Clinical and Basic Investigations into Hermansky-Pudlak Syndrome
Conditions: Albinism; Intestinal Disease; Kidney Disease; Myocardial Disease; Pulmonary Fibrosis |
| 24. | | Recruiting | Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
Conditions: Hypoparathyroidism; Hypercalcemia; Chronic Kidney Disease |
| 25. | | Recruiting | Evaluate the Survival Benefits of Zemplar versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
Condition: End-Stage Kidney Disease |
| 26. | | Recruiting | Combined Bone Marrow and Kidney Transplant for Multiple Myeloma with Kidney Failure
Conditions: Kidney Failure, Chronic; Multiple Myeloma |
| 27. | | Recruiting | Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
Conditions: Kidney Failure; Bone Marrow Transplantation; Kidney Transplantation; Kidney Failure, Chronic |
| 28. | | Recruiting | Pediatric Kidney Transplant without Calcineurin Inhibitors
Condition: End-Stage Renal Disease |
| 29. | | Recruiting | Steroid Treatment for Kidney Disease
Conditions: Nephrosis; Focal Lipoid Glomerulosclerosis |
| 30. | | Recruiting | Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
Condition: Membranous Glomerulonephritis |
| 31. | | Recruiting | Study of Systemic Lupus Erythematosus
Conditions: Lupus Nephritis; Systemic Lupus Erythematosus |
| 32. | | Recruiting | Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
Condition: Kidney Failure, Chronic |
| 33. | | Recruiting | Immune System Related Kidney Disease
Conditions: Glomerulonephritis; Lupus Nephritis; Membranous Glomerulonephritis; Nephritis; Nephrotic Syndrome |
| 34. | | Recruiting | Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
Condition: Kidney Failure, Chronic |
| 35. | | Recruiting | Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell |
| 36. | | Recruiting | Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
Conditions: Melanoma; Kidney Neoplasms; Metastases |
| 37. | | Recruiting | An Investigational Drug in Patients with Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
Conditions: Diabetes Mellitus, Type 2; Chronic Renal Insufficiency |
| 38. | | Recruiting | Treating Systemic Lupus Erythematosus (SLE) Patients with CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic; Lupus Nephritis |
| 39. | | Recruiting | Cellular Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 40. | | Recruiting | Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
| 41. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 42. | | Recruiting | Treatment of Patients with Metastatic Renal Cell Cancer Using Cultured Tumor-Reactive Lymphocytes and Interleukin-2
Condition: Kidney Neoplasms |
| 43. | | Recruiting | Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 44. | | Recruiting | Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma |
| 45. | | Recruiting | PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
Condition: Stage IV Renal Cell Cancer |
| 46. | | Recruiting | Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
Condition: Kidney Failure, Chronic |
| 47. | | Recruiting | Study of LJP 394 in Lupus Patients with History of Renal Disease
Conditions: Lupus Erythematosus, Systemic; Lupus Nephritis |
| 48. | | Not yet recruiting | SU011248 in the Treatment of Patients with Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma |
| 49. | | Recruiting | Study of Terlipressin vs. Placebo to Treat Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome |
| 50. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome |
